Jesse Seton McGreivy

Jesse Seton McGreivy

Chief Executive Officer at Kartos Therapeutics, Inc.

54 year
100 connections
Health Technology
Consumer Services

Active connections

NameGenderAgeLinked companiesCollaboration
Iain Dukes M 65
Kartos Therapeutics, Inc.
Logo Kartos Therapeutics, Inc.

Kartos Therapeutics, Inc.

Pharmaceuticals: MajorHealth Technology

Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy.

 11 years
Wayne P. Rothbaum M 56
Kartos Therapeutics, Inc.
Logo Kartos Therapeutics, Inc.

Kartos Therapeutics, Inc.

Pharmaceuticals: MajorHealth Technology

Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy.

 -
Ronald Sugar M 75 14 years
Tyler Jacks M 63 12 years
Esteban Santos M 56 17 years
Roger Ulrich M -
Kartos Therapeutics, Inc.
Logo Kartos Therapeutics, Inc.

Kartos Therapeutics, Inc.

Pharmaceuticals: MajorHealth Technology

Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy.

 -
Maria Fardis M 56
Kartos Therapeutics, Inc.
Logo Kartos Therapeutics, Inc.

Kartos Therapeutics, Inc.

Pharmaceuticals: MajorHealth Technology

Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy.

 -
Flavia Borellini M 65
Kartos Therapeutics, Inc.
Logo Kartos Therapeutics, Inc.

Kartos Therapeutics, Inc.

Pharmaceuticals: MajorHealth Technology

Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy.

 6 years
See more

Connections Chart

Multi-company connection

Former connections

NameGenderAgeLinked companiesCollaboration
Pamela Wapnick F 58 9 years
Dennis Fenton M 72 27 years
Marc M. P. de Garidel M 66 15 years
Craig Shepherd M - 7 years
William P. Sheridan M 69 5 years
Steven Galson M 67 -
James Daly M 63 9 years
Preston Klassen M 55 7 years
John Moriarty M 56 6 years
Vasant Prakash Gandhi M - 5 years
Marco Renoldi M 67 3 years
Thomas Zindrick M 65 8 years
Laurie Stelzer F 56 2 years
Robert Azelby M 56 5 years
Joseph Newell M 54 7 years
Andreas Grauer M 63 -
Nathan Hardy M 48 10 years
Rachel Lenington F 51 10 years
Cynthia Flowers F 64 5 years
George Morrow M 72 10 years
Thomas Johannes W. Dittrich M 60 4 years
Frederick Gluck M 88 13 years
François de Carbonnel M 78 10 years
Vance D. Coffman M 79 9 years
Jin Long Chen M 61 4 years
Rebecca M. Henderson M 63 11 years
Peter Carbone M - 3 years
David Hovland M - 8 years
David Essayan M - 4 years
Alexandra Pearce M - 4 years
NgocDiep Le M 56 3 years
Wen Chen Yeh M 61 10 years
Eliot Charles M 62 3 years
Catherine Lee Kelleher M - 7 years
David Green M - 11 years
Joanne Viney M 58 9 years
Shamim Ruff F 64 4 years
Winston Kung M 48 3 years
Ann Miller M 66 5 years
Linda C. Heller F 60 4 years
George G Nomikos M - 1 years
Sohanya Cheng F 41 11 years
Kimberly Ann Davis F 56 11 years
Guy Padbury M - 7 years
Ann Merchant F 59 17 years
Mike Nanfito M - 4 years
Adrian Otte M - 11 years
Jolanda Grob F 51 4 years
Deborah Wenkert M 65 6 years
Kenneth Lock M 50 6 years
Helen Torley M 61 8 years
Richard Williams M 55 2 years
Christophe Quéva M 57 5 years
Sesha Neervannan M 56 8 years
Paul Romness M 57 3 years
Xue Ming Qian M 57 13 years
Richard Nanula M 63 6 years
Timothy Powers M 58 5 years
Joseph Leveque M 63 2 years
Ellen Feigal M 69 3 years
Warren Wayne Myers M 62 10 years
Randal A. Hassler M 66 12 years
F. Carsten Thiel M 61 3 years
H. Christian Fibiger M 80 4 years
Andrew Gengos M 59 8 years
Kevin L. Stark M - 15 years
Fanesca Young M - 2 years
Robert M. Brenner M 56 9 years
Kurt Gustafson M 56 18 years
Grove Matsuoka M - 12 years
Lisa Guttman F - 7 years
Alex Virgilio M - 4 years
Xiao Dong Yang M 64 -
Lisa A. Evrén F - 5 years
Krishna R. Polu M 50 2 years
Juan Jaen M 66 10 years
Jude Dinges M - -
Steven J. Ruhl M - -
Mahesh Krishnan M 53 5 years
Lauro A. González Moreno M 62 -
David A. Piacquad M 67 12 years
Marlene Haffner M 83 2 years
Rizwana F. Sproule M 61 6 years
Dennis Hom M 48 1 years
Vimal Srivastava M 58 3 years
Riccardo Perfetti M 64 3 years
Roger Perlmutter M 71 11 years
Sandra Milligan M - 10 years
Robert Coffin M 59 2 years
Roy Baynes M 69 10 years
Gordon Ng M - 9 years
David Lacey M 71 17 years

Statistics

CountryConnections% of total
United States 100 100.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections

  1. Stock Market
  2. Insiders
  3. Jesse Seton McGreivy
  4. Personal Network
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW